China Medicine Corporation (OTCPK: CHME)
Health Care · Pharmaceuticals · CN
$0.02
-49.51% today · +1763.6% 1Y
China Medicine Corporation (OTCPK: CHME) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $490.24K and employs 281 people.
Over the last twelve months the share price has gained 1763.6%, trading between 0.00 and 0.06.
Tweenvest scores China Medicine Corporation across four factors: value 0/100. Its strongest factor is value.
CHME price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $490.24K
- Revenue (TTM)
- $65.76M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 228.90
- 52-week high
- $0.06
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.91M
- Employees
- 281
- Next earnings
- —
About China Medicine Corporation
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
- ISIN
- US1694911074
- Founded
- 2005
- Listed since
- Nov 30, 2006
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.